Douglas V Faller

7PUBLICATIONS
31CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.

Toshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin

|Jun 25, 2021
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis.

Angela Dispenzieri, Efstathios Kastritis, Ashutosh D Wechalekar

|Apr 30, 2021
Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models.

Fabien Muselli, Lucas Mourgues, Rita Morcos

Pageof 2